Proceedings of the National Academy of Sciences · 1998 · 165 citations · 35 references
Life SciencesCell BiologyMolecular BiologyCell SignalingImmunopathologyMolecular Cell BiologyEndothelial ActivationEndothelial DysfunctionAntibodiesHigh-molecular-weight KininogenKallikrein-kinin SystemProtein Binding Domains
A kininogen binding protein(s), a putative receptor, was identified on endothelial cells. A 54-kDa protein was isolated by a biotin-high molecular mass kininogen (HK) affinity column that, on aminoterminal sequencing of tryptic digests, was identified as cytokeratin 1. Multiple antibodies directed to cytokeratin 1 reacted with a 54-kDa band on immunoblot of lysates of endothelial cells. On laser scanning confocal microscopy, cytokeratin 1 antigen was found on the surface of endothelial cells. Cytokeratin 1 antigen also was detected on endothelial cell membranes by flow cytometry. Moreover, an antipeptide antibody to a sequence unique to cytokeratin 1 also specifically bound to nonpermeabilized endothelial cells. Biotin-HK specifically bound to cytokeratin only in the presence of Zn2+, and cytokeratin blocked biotin-HK binding to endothelial cells. Further, HK and low molecular mass kininogen, but not factor XII, blocked biotin-HK binding to cytokeratin, and peptides of each cell binding region of HK on domains 3,4, and 5 blocked biotin-HK binding to cytokeratin. gC1qR and soluble urokinase-like plasminogen activator receptor also inhibited biotin-HK binding to cytokeratin. These investigations identify a new function for cytokeratin 1 as a kininogen binding protein. Cytokeratins, members of the family of intermediate filament proteins, may represent a new class of receptors.
35
Expression cloning of a human B1 bradykinin receptor.
John G. Menke, Joseph A. Borkowski, Kathleen K. Bierilo et al. · Journal of Biological Chemistry · 1994 · 465 citations · Full text
Berhane Ghebrehiwet, Boon Leong Lim, Ellinor I.B. Peerschke et al. · The Journal of Experimental Medicine · 1994 · 345 citations · Full text